Clinical Trials List
Protocol NumberNN1250-3668
2009-12-01 - 2010-09-30
Phase III
Terminated3
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- - - Division of Endocrinology
- CHIH-YUAN WANG CHIH-YUAN WANG Division of Endocrinology
- 李弘元 Division of Endocrinology
- CHIH-YUAN WANG Division of Endocrinology
- 張恬君 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Harn-Shen Chen Division of Endocrinology
- Ching Fai Kwok Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Tsueng He Division of Endocrinology
- 謝昌勳 Division of Endocrinology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
65 participants
-
Global
965 participants
